Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  GenSight Biologics S.A.    SIGHT   FR0013183985

GENSIGHT BIOLOGICS S.A.

(SIGHT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GENSIGHT BIOLOGICS S.A.
11/04GENSIGHT BIOLOGICS S A : reports validation of LUMEVOQ Marketing Authorisation A..
AQ
11/03GENSIGHT BIOLOGICS S A : reports validation of LUMEVOQ® Marketing Authorisation ..
PU
11/03GENSIGHT BIOLOGICS : Reports Validation of LUMEVOQ® Marketing Authorisation Appl..
BU
10/23GENSIGHT BIOLOGICS S A : successfully raises EUR25 million in an oversubscribed ..
AQ
10/22GENSIGHT BIOLOGICS S A : Securities Note
PU
10/22GENSIGHT BIOLOGICS S A : Amendment to the 2019 Universal Registration Document
PU
10/22GENSIGHT BIOLOGICS S A : launches a capital increase of approximately EUR25 mill..
AQ
10/22GENSIGHT BIOLOGICS S A : successfully raises €25 million in an oversubscribed pr..
PU
10/22GENSIGHT BIOLOGICS S A : Successfully Raises €25 Million in an Oversubscribed Pr..
BU
10/21GENSIGHT BIOLOGICS S A : launches a capital increase of approximately €25 millio..
PU
10/16GENSIGHT BIOLOGICS S A : Reports Cash Position as of September 30, 2020 and Prov..
AQ
10/15GENSIGHT BIOLOGICS S A : Appoints Elsy Boglioli to its Board of Directors
AQ
10/15GENSIGHT BIOLOGICS S A : Reports Cash Position as of September 30, 2020 and Prov..
PU
10/15GENSIGHT BIOLOGICS S A : Reports Cash Position as of September 30, 2020 and Prov..
BU
10/14GENSIGHT BIOLOGICS S A : Appoints Elsy Boglioli to its Board of Directors
PU
10/14GENSIGHT BIOLOGICS : Appoints Elsy Boglioli to Its Board of Directors
BU
10/12GENSIGHT BIOLOGICS S A : Corporate presentation, October 2020
PU
09/29GENSIGHT BIOLOGICS S A : Announces Publication of Meta-Analysis Confirming that ..
AQ
09/28GENSIGHT BIOLOGICS : Announces Publication of Meta-Analysis Confirming that Spon..
BU
09/21GENSIGHT BIOLOGICS S A : reports new analysis demonstrating statistically signif..
AQ
09/21GENSIGHT BIOLOGICS S A : Corporate presentation, September 2020
PU
09/21GENSIGHT BIOLOGICS S A : reports new analysis demonstrating statistically signif..
PU
09/21GENSIGHT BIOLOGICS : Reports New Analysis Demonstrating Statistically Significan..
BU
09/16GENSIGHT BIOLOGICS S A : Submits EU Marketing Authorisation Application for LUME..
AQ
09/15GENSIGHT BIOLOGICS S A : Submits EU Marketing Authorisation Application for LUME..
PU
09/15GENSIGHT BIOLOGICS S A : Submits EU Marketing Authorisation Application for LUME..
BU
08/04GENSIGHT BIOLOGICS : Draws Down the €4 Million Second Tranche of Bonds From Kreo..
BU
07/30GENSIGHT BIOLOGICS S A : 2020 Half-Year Financial Report
PU
07/30GENSIGHT BIOLOGICS S A : Reports Interim Financial Results for the First Half of..
BU
07/21GENSIGHT BIOLOGICS : Reports Final REALITY Natural History Study Results Confirm..
BU
07/10GENSIGHT BIOLOGICS S A : obtains a EUR7m non-dilutive loan and renegotiates the ..
AQ
07/09GENSIGHT BIOLOGICS : Obtains a €7m Non-Dilutive Loan and Renegotiates the Bond A..
BU
07/07GENSIGHT BIOLOGICS S A : Corporate presentation, June 2020
PU
07/06GENSIGHT BIOLOGICS : Reports Sustained Efficacy and Safety Among LHON Patients T..
BU
07/02GENSIGHT BIOLOGICS : to Host LUMEVOQ® Key Opinion Leader Call on July 9, 2020
BU
04/24GENSIGHT BIOLOGICS : will hold its General Meeting on April 29, 2020 behind clos..
AQ
04/22GENSIGHT BIOLOGICS : Will Hold Its General Meeting on April 29, 2020 Behind Clos..
BU
04/21GENSIGHT BIOLOGICS : Reports Cash Position as of March 31, 2020 and Provides Ope..
BU
04/16GENSIGHT BIOLOGICS : on Track to Submit LUMEVOQ for European Approval in Septemb..
AQ
04/15GENSIGHT BIOLOGICS : Announces Positive Data Safety Monitoring Board Review of P..
AQ
04/15GENSIGHT BIOLOGICS : on Track to Submit LUMEVOQ® for European Approval in Septem..
BU
04/14GENSIGHT BIOLOGICS : Announces Positive Data Safety Monitoring Board Review of P..
BU
04/09GENSIGHT BIOLOGICS : Annual General Meeting on April 29, 2020 Procedures for obt..
AQ
04/08GENSIGHT BIOLOGICS : Annual General Meeting on April 29, 2020 Procedures for obt..
PU
04/08GENSIGHT BIOLOGICS : Annual General Meeting on April 29, 2020
BU
04/08GENSIGHT BIOLOGICS : Announces the Filing of its 2019 Universal Registration Doc..
BU
04/08GENSIGHT BIOLOGICS : Nominees to the Board of Directors
PU
04/08GENSIGHT BIOLOGICS : Explanatory statement
PU
04/06GENSIGHT BIOLOGICS : Provides Update on Operations in the Context of COVID-19
PU
04/06GENSIGHT BIOLOGICS :  GenSight Biologics Provides Update on Operations in the Co..
BU
03/12GENSIGHT BIOLOGICS : Reports Full Year 2019 Financial Results and Provides an Ou..
BU
03/04GENSIGHT BIOLOGICS : announces presentation of bilateral visual recovery from GS..
AQ
03/03GENSIGHT BIOLOGICS : Announces Presentation of Bilateral Visual Recovery From GS..
BU
01/21GENSIGHT BIOLOGICS : Reports Its Cash Position as of December 31, 2019 and Provi..
BU
01/20GENSIGHT BIOLOGICS : Announces its 2020 Financial Calendar
BU
2019GENSIGHT BIOLOGICS : Announces the Filing of its 2018 Universal Registration Doc..
AQ
2019GENSIGHT BIOLOGICS : obtains EUR15 million in financing through a bond issuance ..
AQ
2019GENSIGHT BIOLOGICS : Announces the Filing of its 2018 Universal Registration Doc..
BU
2019GENSIGHT BIOLOGICS : Obtains €15 Million in Financing Through a Bond Issuance fr..
BU
2019GENSIGHT BIOLOGICS : reports findings from REALITY study and REVERSE-RESCUE anal..
AQ
2019GENSIGHT BIOLOGICS : The Quinze-Vingts Hospital and GenSight Biologics announce ..
AQ
2019GENSIGHT BIOLOGICS : Corporate presentation, November 2019
PU
2019GENSIGHT BIOLOGICS : Corporate presentation, October 2019
PU
2019GENSIGHT BIOLOGICS : to present new GS010 data at the 2019 Annual Meeting of the..
PU
2019GENSIGHT BIOLOGICS : integrates the Enternext® PEA-PME 150 index by Euronext
PU
2019GENSIGHT BIOLOGICS : Corporate presentation, September 2019
PU
2019GENSIGHT BIOLOGICS : Corporate presentation, July 2019
PU
2019GENSIGHT BIOLOGICS : completes enrollment of GS010 REFLECT Phase III trial in th..
PU
2019GENSIGHT BIOLOGICS : Corporate presentation, May 2019
PU
2019GENSIGHT BIOLOGICS : BALO prior notification
PU
2019GENSIGHT BIOLOGICS : Annual General Meeting on June 11, 2019
PU
2019GENSIGHT BIOLOGICS : Explanatory Statement – 2019 General Meeting
PU
2019GENSIGHT BIOLOGICS : Nominees to the Board of Directors
PU
2019GENSIGHT BIOLOGICS : Notice of General Meeting on June 11, 2019
PU
2019GENSIGHT BIOLOGICS : Corporate presentation, April 2019
PU
1  2Next
Upcoming event on GENSIGHT BIOLOGICS S.A.